Save your place

Sign in to WhoBought

Please try again later.

Immunocore Holdings plc (IMCR) institutional ownership

Market cap$1.7B SectorHealthcare
Funds holding · Q1 2026
145
reported IMCR position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
73 buyers · 72 sellers

Immunocore Holdings plc (IMCR) price and institutional activity

Dates

Q1 2026

$0 bought by 73 investors
Vestal Point Capital, LPTwo Sigma Investments, LP +71 more
$0 sold by 72 investors
T. Rowe Price Investment Management, Inc.Baker Bros. Advisors LP +70 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Immunocore Holdings plc (IMCR) institutional activity · 145

Investor Type Est. change Change Δ Own Date
T. Rowe Price Investment Management, Inc. · Reduced
Change −4.1M Date Q1 2026
T. Rowe Price Investment Management, Inc. Reduced· Q1 2026 −4.1M Q1 2026
Vestal Point Capital, LP · Added
Change +2.2M Date Q1 2026
Vestal Point Capital, LP Added· Q1 2026 +2.2M Q1 2026
Baker Bros. Advisors LP · Reduced
Change −1.6M Date Q1 2026
Baker Bros. Advisors LP Reduced· Q1 2026 −1.6M Q1 2026
Two Sigma Investments, LP · Added
Change +662K Δ Own +184.2% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +662K +184.2% Q1 2026
Logos Global Management LP · Added
Change +650K Date Q1 2026
Logos Global Management LP Added· Q1 2026 +650K Q1 2026
Point72 Asset Management, L.P. · Added
Change +598K Δ Own +118.6% Date Q1 2026
Point72 Asset Management, L.P. Added· Q1 2026 +598K +118.6% Q1 2026
Caption Management, LLC · Added
Change +567K Date Q1 2026
Caption Management, LLC Added· Q1 2026 +567K Q1 2026
BlackRock · Added
Change +327K Date Q1 2026
BlackRock Added· Q1 2026 +327K Q1 2026
Millennium Management LLC · Added
Change +326K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +326K Q1 2026
Two Sigma Advisers, LP · Exited
Change −322K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −322K −100.0% Q1 2026
FMR LLC · Added
Change +290K Δ Own +6.4% Date Q1 2026
FMR LLC Added· Q1 2026 +290K +6.4% Q1 2026
Primecap Management Co · Reduced
Change −269K Date Q1 2026
Primecap Management Co Reduced· Q1 2026 −269K Q1 2026
Cantor Fitzgerald, L. P. · New
Change +250K Date Q1 2026
Cantor Fitzgerald, L. P. New· Q1 2026 +250K Q1 2026
Hudson Bay Capital Management LP · Added
Change +250K Date Q1 2026
Hudson Bay Capital Management LP Added· Q1 2026 +250K Q1 2026
Moore Capital Management, LP · New
Change +197K Date Q1 2026
Moore Capital Management, LP New· Q1 2026 +197K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 145

Famous investor activity in Immunocore Holdings plc (IMCR)

Immunocore Holdings plc (IMCR) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Ratcliffe Peter John · Director Grant (A) 27K
Owned 27K Trade date May 27, 2026 Filed date May 28, 2026
Ratcliffe Peter John Director Grant (A) 27K 27K May 27, 2026 May 28, 2026
Peterson Kristine · Director Grant (A) 27K
Owned 27K Trade date May 27, 2026 Filed date May 28, 2026
Peterson Kristine Director Grant (A) 27K 27K May 27, 2026 May 28, 2026
Pao William · Director Grant (A) 27K
Owned 27K Trade date May 27, 2026 Filed date May 28, 2026
Pao William Director Grant (A) 27K 27K May 27, 2026 May 28, 2026
Kaul Siddharth · Director Grant (A) 27K
Owned 27K Trade date May 27, 2026 Filed date May 28, 2026
Kaul Siddharth Director Grant (A) 27K 27K May 27, 2026 May 28, 2026
Herbst Roy Steven · Director Grant (A) 27K
Owned 27K Trade date May 27, 2026 Filed date May 28, 2026
Herbst Roy Steven Director Grant (A) 27K 27K May 27, 2026 May 28, 2026
Bell John Irving · Director Grant (A) 27K
Owned 27K Trade date May 27, 2026 Filed date May 28, 2026
Bell John Irving Director Grant (A) 27K 27K May 27, 2026 May 28, 2026
Jallal Bahija · Director, Officer Sell −$371K
Price $32.35 Qty −11K Owned 12K Trade date Feb 18, 2026 Filed date Feb 19, 2026
Jallal Bahija Director, Officer Sell $32.35 −11K −$371K 12K Feb 18, 2026 Feb 19, 2026
Goll John · Officer Sell −$23K
Price $32.35 Qty −698 Owned 653 Trade date Feb 18, 2026 Filed date Feb 19, 2026
Goll John Officer Sell $32.35 −698 −$23K 653 Feb 18, 2026 Feb 19, 2026
St Leger Tina Amber · Officer Sell −$32K
Price $32.35 Qty −1K Owned 1K Trade date Feb 18, 2026 Filed date Feb 19, 2026
St Leger Tina Amber Officer Sell $32.35 −1K −$32K 1K Feb 18, 2026 Feb 19, 2026
Berman David M. · Officer Sell −$193K
Price $32.35 Qty −6K Owned 6K Trade date Feb 18, 2026 Filed date Feb 19, 2026
Berman David M. Officer Sell $32.35 −6K −$193K 6K Feb 18, 2026 Feb 19, 2026
Coy Travis Alan · Officer 2 operations 129K
Owned 33K Trade date Feb 17, 2026 Filed date Feb 19, 2026
Coy Travis Alan Officer 2 operations 129K 33K Feb 17, 2026 Feb 19, 2026
Jallal Bahija · Director, Officer 2 operations 0
Owned 71K Trade date Feb 17, 2026 Filed date Feb 19, 2026
Jallal Bahija Director, Officer 2 operations 0 71K Feb 17, 2026 Feb 19, 2026
Jallal Bahija · Director, Officer 2 operations 484K
Owned 395K Trade date Feb 17, 2026 Filed date Feb 19, 2026
Jallal Bahija Director, Officer 2 operations 484K 395K Feb 17, 2026 Feb 19, 2026
Goll John · Officer 2 operations 0
Owned 4K Trade date Feb 17, 2026 Filed date Feb 19, 2026
Goll John Officer 2 operations 0 4K Feb 17, 2026 Feb 19, 2026
Goll John · Officer 2 operations 29K
Owned 7K Trade date Feb 17, 2026 Filed date Feb 19, 2026
Goll John Officer 2 operations 29K 7K Feb 17, 2026 Feb 19, 2026
15 of 17
15 of 17 Sign in to continue to older insider transactions.

Immunocore Holdings plc (IMCR) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Wellington Management Group LLP 7.3M
% of shares outstanding 14.8% Filing date Nov 8, 2024
Wellington Management Group LLP 7.3M 14.8% Nov 8, 2024
FMR LLC 4.4M
% of shares outstanding 10.0% Filing date Mar 11, 2024
FMR LLC 4.4M 10.0% Mar 11, 2024
Rtw Investments, LP 4.9M
% of shares outstanding 9.7% Filing date Nov 14, 2024
Rtw Investments, LP 4.9M 9.7% Nov 14, 2024
Vestal Point Capital, LP 2.8M
% of shares outstanding 5.5% Filing date May 15, 2026
Vestal Point Capital, LP 2.8M 5.5% May 15, 2026
Cross Nicholas John 2.4M
% of shares outstanding 5.4% Filing date Mar 17, 2022
Cross Nicholas John 2.4M 5.4% Mar 17, 2022
Laing Ian Michael 2.4M
% of shares outstanding 5.4% Filing date Feb 18, 2022
Laing Ian Michael 2.4M 5.4% Feb 18, 2022
Baker Bros. Advisors LP 2.5M
% of shares outstanding 5.0% Filing date Feb 1, 2024
Baker Bros. Advisors LP 2.5M 5.0% Feb 1, 2024
T. Rowe Price Associates 2.3M
% of shares outstanding 4.7% Filing date Nov 14, 2024
T. Rowe Price Associates 2.3M 4.7% Nov 14, 2024
8 of 12

Immunocore Holdings plc (IMCR) ownership FAQ

Who owns IMCR?

145 reporting institutions disclosed IMCR position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.